Insider trade

Insmed (INSM): CEO sold ~$504K

William Lewis, CEO at Insmed, sold ~$504K of Insmed shares.

~$504K
Approx. value · 6,847 sh @ $73.56
385K
Holds after · shares reported
Traded
Dec 12, 2024
Filed
Dec 13, 2024

What stands out in this filing

  • The sale was 1.7% of the shares this insider held before it; the filing reports 385,359 shares afterwards.
  • 6,847 shares at an average of $73.56 each, as reported on the form.
  • Footnote references a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 12, 2024 · this disclosureInsiderCEO sold ~$504K of INSM shares in the open market

What came next

  1. Dec 12, 2024Insider · 1 personInsiders: 5 sales (~$1.4M)
  2. Dec 19, 2024Insider · 1 personInsiders: 4 sales (~$1.8M)
  3. Jan 2, 2025Insider · 1 personInsiders: 2 sales (~$1.8M)
  4. Jan 7, 2025Insider · 7 peopleInsiders: 8 sales (~$2.3M)
  5. Jan 8, 2025Insider · 7 peopleInsiders: 7 sales (~$773K)
  6. Jan 10, 2025Insider · 7 peopleInsiders: 10 sales (~$1.3M)
  7. Jan 14, 2025Insider · 3 peopleInsiders: 3 sales (~$255K)
  8. Jan 15, 2025Insider · 1 personInsiders: 6 sales (~$2.7M)
  9. Jan 30, 2025InsiderOfficer sold ~$7.29M of INSM shares in the open market
  10. Feb 3, 2025Insider · 1 personInsiders: 8 sales (~$2.0M)
  11. Feb 6, 2025Insider · 7 peopleInsiders: 7 sales (~$19.3M)
  12. Feb 7, 2025Insider · 3 peopleInsiders: 3 sales (~$14K)
  13. Feb 10, 2025Insider · 2 peopleInsiders: 6 sales (~$6.4M)
  14. Feb 11, 2025InsiderCFO sold ~$1.06M of INSM shares in the open market
  15. Feb 12, 2025InsiderCFO sold ~$402K of INSM shares in the open market
  16. Feb 18, 2025Insider · 2 peopleInsiders: 7 sales (~$3.5M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Insmed

For Insmed, OQRO holds 5 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its INSM page.

Other recent filings by William Lewis, Chair and CEO

The full history of William Lewis, Chair and CEO is on the profile page.

How this filing works

Explore the data

Common questions

Which Insmed (INSM) insider traded, and how much?

William Lewis, CEO at Insmed, sold ~$504K of Insmed shares. 6,847 shares at $73.56.

When did it happen, and when was it made public?

Traded: Dec 12, 2024. Filed: Dec 13, 2024. That is 1 day between the two dates.

What stands out in this filing?

The sale was 1.7% of the shares this insider held before it; the filing reports 385,359 shares afterwards. 6,847 shares at an average of $73.56 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Insmed recently?

For Insmed, OQRO holds 5 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days. They are listed on the INSM page.

Does this mean INSM stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Insmed

Everything OQRO holds on this company is on its INSM page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data